New tool aims to better measure breathlessness in lung patients
NCT ID NCT02229994
First seen Jun 26, 2026 · Last updated Jun 27, 2026 · Updated 1 time
Summary
This study tested a new self-administered questionnaire called DYSLIM to measure shortness of breath and its impact on daily life in people with chronic respiratory diseases like COPD, cystic fibrosis, and pulmonary hypertension. Researchers enrolled 199 participants to check if the questionnaire is reliable and accurate. The goal is to give doctors a simple, practical tool to assess breathlessness in routine care.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
- What this could lead to
- If successful, this could give doctors a better tool to measure and track shortness of breath in patients with chronic lung diseases.
- What could go wrong
- This is an early-stage study focused on developing a questionnaire, not testing a treatment. It may not lead to immediate changes in patient care.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for COPD (WITH - WITHOUT REHABILITATION) are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Service de Pneumologie AP-HP, Hôpitaux Universitaires Paris Centre
Paris, 75006, France
More trials for these conditions
Other studies related to the condition(s) this trial covers.